ClinicalTrials.gov
ClinicalTrials.gov Menu

Accuracy of 5D LB Ultrasound in Prediction of Birth Weight in Macrosomic Babies : A Pilot Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02396667
Recruitment Status : Recruiting
First Posted : March 24, 2015
Last Update Posted : July 18, 2017
Sponsor:
Information provided by (Responsible Party):
dr mohamed laban, Ain Shams University

Brief Summary:
5D and 2D ultrasounds will be done for pregnant women with macrosomic fetuses to determine estimated fetal weight using hadlock formula. The accuracy of fetal weight obtained by ultrasound will be compared to actual birth weight.

Condition or disease Intervention/treatment
Macrosomia Other: 5D ultrasound

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Accuracy of 5D LB Ultrasound in Prediction of Birth Weight in Macrosomic Babies: A Pilot Study
Study Start Date : March 2015
Estimated Primary Completion Date : September 2017
Estimated Study Completion Date : September 2017

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
pregnant women with macrosomia
Pregnant wo.en between 37 and 42 weeks with fetal macrosomia as suspected by clinical estimation and 2D ultrasound.
Other: 5D ultrasound



Primary Outcome Measures :
  1. Accuracy of 5D ultrasound in predicting actual birth weight in comparison to 2D ultrasound. (estimated by hadlock formula - Accuracy of estimated fetal weight by ultrasound will be compared to actual birth weight) [ Time Frame: 72hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Pregnant women between 37 and 42 weeks with macrosomic fetuses.
Criteria

Inclusion Criteria:

  • 37 to 42 weeks gestation
  • macrosomic fetuses
  • maternal diabetes

Exclusion Criteria:

  • intrauterine fetal death
  • multiple pregnancy
  • congenital anomaly
  • nonvisualized fetal parts

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02396667


Contacts
Contact: Mohammed Laban, MD laban63@yahoo.com
Contact: Alaa Hassanin, MD 01002554281 alaasayed80@hotmail.com

Locations
Egypt
Ain Shams Maternity Hospital Recruiting
Cairo, Egypt
Contact: Mohammed Laban, MD    0    laban63@yahoo.com   
Contact: Alaa Hassanin, MD    01002554281    alaasayed80@hotmail.com   
Principal Investigator: mohammed Laban, MD         
Sub-Investigator: alaa hassanin, MD         
Sponsors and Collaborators
Ain Shams University

Responsible Party: dr mohamed laban, professor, Ain Shams University
ClinicalTrials.gov Identifier: NCT02396667     History of Changes
Other Study ID Numbers: m2493
First Posted: March 24, 2015    Key Record Dates
Last Update Posted: July 18, 2017
Last Verified: July 2017

Additional relevant MeSH terms:
Birth Weight
Body Weight
Signs and Symptoms